
Head and neck manifestations in HIV infection - PubMed
The advent of highly active anti-retroviral therapy (HAART) has transformed the prevalence of HIV-associated head and neck disease. This article reviews the clinical presentations and treatments of common and uncommon head and neck manifestations in HIV infection.
Increased risk of deep neck infection among HIV-infected …
2013年4月22日 · Deep neck infections (DNIs) in HIV-infected patients often produce severe complications, even death. Data on the incidence rates and risks of DNI among HIV-infected patients are scarce, particularly with the widespread use of …
“Bullfrog Neck,” a Unique Morphologic Trait in HIV Lipodystrophy
A 38-year old white man with a 10-year history of HIV disease HAART was seen in our clinic for desired improvement of body dysmorphism associated with HIV lipodystrophy. He demonstrated classic features of facial wasting through the mid-malar region and lower cheeks associated with HIV lipoatrophy in addition to buffalo-hump lipohypertrophy of ...
Otorhinolaryngological Manifestations among People Living with HIV…
2024年3月14日 · Most otorhinolaryngological manifestations (ORL-Ms) in people living with HIV (PLWHIV) include head and neck lesions like oral candidiasis, neoplasms such as Kaposi’s sarcoma and inflammatory disorders like rhinosinusitis. Other manifestations include adenoid hypertrophy, chronic suppurative otitis media [9].
Highly Active Antiretroviral Therapy (HAART) - StatPearls - NCBI Bookshelf
2023年7月3日 · Reducing the transmission of HIV-1 to others is a primary goal of HAART. With the use of HAART, a reduction of HIV-1 RNA levels has been shown to reduce the risk of sexual transmission to partners to nearly zero in some studies, even among couples that engaged in condomless sexual acts.
Human Immunodeficiency Virus Infection: Does Highly Active ...
Our study showed a high prevalence of ENT manifestations in HIV patients who were on treatment, irrespective of the gap of 10 years and introduction of HAART therapy. Most common ENT manifestation both in 2004 and 2014 was oropharyngeal candidiasis. Lesser the CD4 count more was the prevalence of disorders in oropharynx.
Update on HAART in HIV - Journal of Hepatology
HAART has changed the clinical profile of HIV infection from a subacute lethal disease to a chronic ambulatory disease. Because current therapy cannot eradicate HIV-infection, the goal of antiretroviral therapy is to achieve and maintain an HIV-RNA copy number in the plasma (viral load) at an undetectable level, using the most sensitive ...
Effect of Combined HAART Plus ATT in Patients of Extrapulmonary ...
Confirmed cases of AIDS with extra pulmonary tuberculosis in head and neck region were studied, keeping all ethical issues in mind and after complete treatment of ATT along with HAART. After treatment, a significant number of patients got resolved with EPTB and gave positive response on their quality of life.
A Real-world Evidence-based Management of HIV by Differential …
The efficacy of highly active antiretroviral therapy (HAART) can be estimated by the immunological response and the incidence of opportunistic infections. This study aimed at evaluating the effectiveness of different durations of HAART in terms of ...
The revolution in AIDS treatment: A comprehensive look at HAART …
2023年10月18日 · One of the primary goals of HAART is to suppress the viral load, which refers to the amount of HIV in the bloodstream. By achieving and maintaining an undetectable viral load, individuals with HIV can lead healthier lives and reduce the risk of transmitting the virus to others.